| Literature DB >> 23304194 |
Lijuan Mei1, Qingyue Chen, Li Ge, Guohua Zheng, Jinxiu Chen.
Abstract
Background. Baduanjin exercise is considered to be beneficial to modulate the blood lipid metabolism. The purpose of the systematic review was to assess the potential efficacy and safety of Baduanjin exercise. Methods. MEDLINE, EMBASE, CBM, CNKI, VIP, Chinese Important Conference Papers Database, and Chinese Dissertation Database were searched for all prospective-controlled trials of Baduanjin exercise from their inception to December 31, 2011. Results. A total of 14 studies were included. Comparing with no treatment, Baduanjin exercise significantly reduced the levels of TC, TG, LDL-C in plasma, and elevated plasma HDL-C level for healthy participants, and the pooled MD (95% confidence interval, CI) was -0.58 mmol/L (-0.86, -0.30 mmol/L), -0.22 mmol/L (-0.31, -0.13 mmol/L), -0.35 mmol/L (-0.54, -0.17 mmol/L), 0.13 mmol/L (0.06, 0.21 mmol/L), respectively. Baduanjin exercise also obviously decreased the levels of TG, LDL-C in plasma comparing with no treatment for patients, and the pooled MD (95% CI) was -0.30 mmol/L (-0.40, -0.19 mmol/L), -0.38 mmol/L (-0.63, -0.13 mmol/L), but there was not obvious to decrease plasma TC level or elevate plasma HDL-C level in patients with the pooled MD (95%CI), -0.39 mmol/L (-1.09, 0.31 mmol/L) and 0.22 mmol/L (-0.11, 0.55 mmol/L), respectively. In addition, the obvious advantage was not observed to modulate the blood lipid metabolism in comparing Baduanjin exercise with other exercises, regardless for health participants or patients. Conclusion. Studies indicated that Baduanjin exercise could significantly decrease the levels of TC, TG, LDL-C levels in plasma and elevate plasma HDL-C level for the healthy people. It also was helpful that Baduanjin exercise modulated the blood lipid metabolism for patients. Moreover, the Baduanjin exercise did not have an obvious advantage on modulating the lipid metabolism comparing with other exercises. But the evidence was uncertain because of the small sample size and low-methodological quality.Entities:
Year: 2012 PMID: 23304194 PMCID: PMC3524626 DOI: 10.1155/2012/282131
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flowchart of trial selection process.
The pooled results of Baduanjin exercise for plasma TC levels in healthy participants or clinical patients.
| Participants | Number of comparisons |
|
| MD (95% CI) |
|
|
|
|---|---|---|---|---|---|---|---|
| Baduanjin + routine versus routine treatment | |||||||
| Clinical patients | 5 | 136 | 136 | −0.56 (−0.74,0.37) |
| 86 |
|
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | −0.39 (−1.09, 0.31) |
| 77 |
|
| Healthy participants | 8 | 110 | 114 | −0.58 (−0.86, −0.3) |
| 41 |
|
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | −0.07 (−0.33,0.19) |
| 0 |
|
| Baduanjin + routine versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | −0.01 (−0.25,0.24) |
| 68 |
|
T: The treatment group, C: The control group.
Figure 2Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
The pooled results of Baduanjin exercise for plasma HDL-C level in healthy participants or clinical patients.
| Participants | Number of comparisons |
|
| MD (95% CI) |
|
|
|
|---|---|---|---|---|---|---|---|
| Baduanjin + routine treatment versus routine treatment | |||||||
| Clinical patients | 5 | 136 | 136 | 0.04 (−0.1, 0.18) |
| 73 |
|
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | 0.22 (−0.11, 0.55) |
| 92 |
|
| Healthy participants | 9 | 140 | 144 | 0.13 (0.06, 0.21) |
| 56 |
|
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | −0.09 (−0.25, 0.06) |
| 19 |
|
| Baduanjin + routine versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | 0.00 (−0.06, 0.07) |
| 0 |
|
T: The treatment group, C: The control group.
The pooled results of Baduanjin exercise for plasma TG level in healthy participants or clinical patients.
| Participants | Numbers of comparisons |
|
| MD (95% CI) |
|
|
|
|---|---|---|---|---|---|---|---|
| Baduanjin + routine treatment versus routine treatment | |||||||
| Clinical patients | 4 | 112 | 112 | −0.77 (−1.97, 0.42) |
| 94 |
|
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | −0.30 (−0.40, −0.19) |
| 42 |
|
| Healthy participants | 4 | 66 | 70 | −0.22 (−0.31, −0.13) |
| 0 |
|
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | −0.21 (−0.51, 0.1) |
| 90 |
|
| Baduanjin + routine treatment versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | 0.1 (−0.14, 0.35) |
| 0 |
|
T: The treatment group, C: The control group.
The pooled results of Baduanjin exercise for plasma LDL-C level in healthy participants or clinical patients.
| Group | Numbers of comparisons |
|
| MD (95% CI) |
|
|
|
|---|---|---|---|---|---|---|---|
| Baduanjin + routine treatment versus routine treatment | |||||||
| Clinical patients | 3 | 88 | 88 | 0.14 (−0.03, 0.31) |
| 60 |
|
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | −0.38 (−0.63, −0.13) |
| 0 |
|
| Healthy participants | 9 | 140 | 144 | −0.35 (−0.54, −0.17) |
| 47 |
|
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | 0.08 (−0.07, 0.23) |
| 74 |
|
| Baduanjin + routine treatment versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | 0.08 (−0.43, 0.58) |
| 88 |
|
T: The treatment group, C: The control group.
Sensitivity analysis of the effect of Baduanjin exercise to clinical patients or healthy participants.
| Before sensitivity analysis | After sensitivity analysis | |||||||
|---|---|---|---|---|---|---|---|---|
| Comparisons | MD (model) |
|
| Method of sensitivity analysis | Comparisons | MD (model) 95% CI |
|
|
| Baduanjin + routine treatment versus routine treatment for TC in clinical patients | ||||||||
| 5 | −0.56 (random) |
| 86 | Remove Zhang 2005 and Zhang 2008 | 3 | −0.83 (fixed) |
| 0 |
| Baduanjin + routine treatment versus other exercises for TC in clinical patients | ||||||||
| 3 | −0.01 (random) |
| 68 | Remove Zhang 2008 | 2 | −0.17 (fixed) |
| 0 |
| Baduanjin + routine treatment versus routine treatment for HDL-C in clinical patients | ||||||||
| 5 | 0.04 (random) (−0.1, 0.18) |
| 73 | Remove Zhang 2008 | 4 | 0.12 (fixed) (0.06, 0.18) |
| 51 |
| Baduanjin versus no treatment for HDL-C in health adults | ||||||||
| 9 | 0.13 (random) (0.06, 0.21) |
| 56 | Remove Liu et al. 2006 | 8 | 0.16 (fixed) (0.11, 0.21) |
| 19 |
| Baduanjin + routine treatment versus routine treatment for TG in clinical patients | ||||||||
| 4 | −0.77 (random) |
| 94 | Remove Wang et al. 2007 | 3 | −0.16 (fixed) (−0.49, 0.17) |
| 0 |
| Baduanjin + routine treatment versus other exercises plus routine treatment for LDL-C in clinical patients | ||||||||
| 3 | 0.08 (random) |
| 88 | Remove Zhou et al. 2011 | 2 | 0.29 (fixed) (0.05, 0.53) |
| 53 |